Lista de obras -

A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome

artículo científico publicado en 2017

A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.

artículo científico publicado en 2018

Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies

artículo científico publicado en 2016

COVID-19 and Cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making

scientific article published on 19 August 2020

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-Distance

artículo científico publicado en 2015

Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case Report

artículo científico publicado en 2017

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

artículo científico

Follow the ATP: tumor energy production: a perspective

artículo científico publicado en 2014

Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.

artículo científico publicado en 2017

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

artículo científico publicado en 2017

Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix

artículo científico publicado en 2020

Rewriting the epigenetic code for tumor resensitization: a review.

artículo científico publicado en 2014

Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

artículo científico publicado en 2016

The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury

artículo científico publicado en 2017

The war on cancer: a military perspective

artículo científico publicado en 2015

Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

artículo científico publicado en 2016

Lista de obras de

A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome

A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.

Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies

COVID-19 and Cancer: A guide with suggested COVID-19 rule-out criteria to support clinical decision-making

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-Distance

Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case Report

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

Follow the ATP: tumor energy production: a perspective

Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix

Rewriting the epigenetic code for tumor resensitization: a review.

Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.

The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury

The war on cancer: a military perspective

Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents